Araris Biotech AG is pioneering a novel linker technology for antibody-drug conjugates (ADCs.) Our linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
Biotechnology Research, Research, general, Research and testing, IT, Internet, R&D, Chemistry, physics and biological engineering consultants, Technical offices and engineering consultancies, architects